Valproate-associated hyperammonemic encephalopathy

Journal of the American Board of Family Medicine

Volumn 20, Issue 5, 2007, Pages 499-502

  Wadzinski, Jim ^a   Franks, Ronald ^a   Roane, David ^b   Bayard, Max ^a,b  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CARNITINE; CLONAZEPAM; FLUVOXAMINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; TRANQUILIZER;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CASE REPORT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; LIVER FUNCTION; MAJOR DEPRESSION; MENTAL DISEASE; MIGRAINE; OFF LABEL DRUG USE; POSTTRAUMATIC STRESS DISORDER; SIDE EFFECT; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COMA; MIDDLE AGED; PATHOPHYSIOLOGY; REVIEW; TOXICITY AND INTOXICATION;

ANTIMANIC AGENTS; BIPOLAR DISORDER; COGNITION DISORDERS; COMA; FEMALE; HUMANS; HYPERAMMONEMIA; MIDDLE AGED; NEUROTOXICITY SYNDROMES; STRESS DISORDERS, POST-TRAUMATIC; VALPROIC ACID;

EID: 35348850012     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2007.05.070062     Document Type: Article

References (18)

1. Gerstner T, Buesing D, Longin E, et al. Valproic acid induced encephalopathy-19 new cases in Germany from 1994 to 2003-a side effect associated to VPA-therapy not only in young children. Seizure 2006;15:443-8.
2. Yehya N, Saldarini CT, Koski ME, Davanzo P. Valproate-induced hyperammonemic encephalopathy. J Am Acad Child Adolesc Psychiatry 2004;43:926-7.
3. Marescaux C, Warter JM, Micheletti G, Rumbach L, Coquillat G, Kurtz D. Stuporous episodes during treatment with sodium valproate: report of seven cases. Epilepsia 1982;23:297-305.
4. Triggs WJ, Gilmore RL, Millington DS, Cibula J, Bunch TS, Harman E. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure. Int J Clin Pharmacol Ther 1997;35:353-6.
5. Murphy JV, Marquardt K. Asymptomatic hyperammonemia in patients receiving valproic acid. Arch Neurol 1982;39:591-2.
6. Hamer HM, Knake S, Schomburg U, Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000;54:230-2.
7. Laub MC, Paetzke-Brunner I, Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia 1986;27:559-62.
8. Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982;101:782-5.
9. Raskind JY, El-Chaar GM. The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother 2000;34:630-8.
10. Bohan TP, Helton E, McDonald I, et al. Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001;56:1405-9.
11. Bohles H, Sewell AC, Wenzel D. The effect of carnitine supplementation in valproate-induced hyperammonaemia. Acta Paediatr 1996;85:446-9.
12. LoVecchio F, Shriki J, Samaddar R. L-carnitine was safely administered in the setting of valproate toxicity. Am J Emerg Med 2005;23:321-2.
13. Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002;17:367-73.
14. Camina MF, Rozas I, Castro-Gago M, Paz JM, Alonso C, Rodriguez-Segade S. Alteration of renal carnitine metabolism by anticonvulsant treatment. Neurology 1991;41:1444-8.
15. Coude FX, Grimber G, Parvy P, Rabier D, Petit F. Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. Biochem J 1983;216:233-6.
16. Oechsner M, Steen C, Sturenburg HJ, Kohlschutter A. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry 1998;64:680-2.
17. Vossler DG, Wilensky AJ, Cawthon DF, et al. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy. Epilepsia 2002;43:154-9.
18. Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996;43:127-70.